Theravance Biopharma to Participate in an Upcoming Investor Conference
Theravance Biopharma (NASDAQ: TBPH) has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference in New York City. The company will engage in a Fireside Chat on Tuesday, September 10 at 10:00 am ET (7:00 am PT/3:00 pm IST). Additionally, Theravance Biopharma will host in-person meetings with the investment community during the conference.
Investors and interested parties can access a webcast of the event through the company's website, Theravance.com, under the Investors section, Events and Presentations. The webcast replay will be available on the company's website for 30 days following the event, providing an opportunity for those unable to attend live to catch up on the discussion.
Theravance Biopharma (NASDAQ: TBPH) ha annunciato la sua partecipazione al 26° Congresso Annuale Globale sugli Investimenti H.C. Wainwright a New York. L'azienda sarà coinvolta in un Fireside Chat Martedì 10 Settembre alle 10:00 ET (7:00 PT / 15:00 IST). Inoltre, Theravance Biopharma ospiterà incontri di persona con la comunità degli investitori durante il congresso.
Gli investitori e le parti interessate possono accedere a un webcast dell'evento attraverso il sito web dell'azienda, Theravance.com, nella sezione Investitori, Eventi e Presentazioni. La registrazione del webcast sarà disponibile sul sito web dell'azienda per 30 giorni dopo l'evento, offrendo a coloro che non possono partecipare dal vivo l'opportunità di recuperare la discussione.
Theravance Biopharma (NASDAQ: TBPH) ha anunciado su participación en la 26ª Conferencia Anual Global de Inversión H.C. Wainwright en Nueva York. La compañía participará en una charla Fireside el martes 10 de septiembre a las 10:00 am ET (7:00 am PT / 3:00 pm IST). Además, Theravance Biopharma organizará reuniones presenciales con la comunidad de inversionistas durante la conferencia.
Los inversionistas y partes interesadas pueden acceder a una transmisión del evento a través del sitio web de la compañía, Theravance.com, en la sección de Inversores, Eventos y Presentaciones. La repetición de la transmisión estará disponible en el sitio web de la compañía durante 30 días después del evento, brindando una oportunidad para aquellos que no pueden asistir en vivo para ponerse al día con la discusión.
Theravance Biopharma (NASDAQ: TBPH)는 뉴욕에서 열리는 H.C. Wainwright 제26회 연례 글로벌 투자 컨퍼런스에 참여한다고 발표했습니다. 회사는 9월 10일 화요일 오전 10:00 ET (오전 7:00 PT / 오후 3:00 IST) 에서 Fireside Chat을 진행합니다. 또한, Theravance Biopharma는 컨퍼런스 기간 동안 투자자 커뮤니티와의 대면 회의를 주최할 예정입니다.
투자자 및 관심 있는 모든 분들은 회사 웹사이트인 Theravance.com의 투자자 섹션, 이벤트 및 발표 옵션을 통해 이벤트의 웹캐스트에 접근할 수 있습니다. 웹캐스트 다시보기는 이벤트 후 30일간 회사 웹사이트에서 제공되어, 생방송에 참석할 수 없는 분들이 논의를 따라잡을 수 있는 기회를 제공합니다.
Theravance Biopharma (NASDAQ: TBPH) a annoncé sa participation à la 26ème Conférence Annuelle Globale d'Investissement H.C. Wainwright à New York. La société participera à un Fireside Chat le mardi 10 septembre à 10h00 ET (7h00 PT / 15h00 IST). De plus, Theravance Biopharma organisera des réunions en personne avec la communauté des investisseurs lors de la conférence.
Les investisseurs et les parties intéressées peuvent accéder à un webcast de l'événement via le site Web de l'entreprise, Theravance.com, dans la section Investisseurs, Événements et Présentations. Le replay du webcast sera disponible sur le site de l'entreprise pendant 30 jours suivant l'événement, offrant ainsi l'opportunité à ceux qui n'ont pas pu assister en direct de rattraper la discussion.
Theravance Biopharma (NASDAQ: TBPH) hat seine Teilnahme an der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright in New York bekannt gegeben. Das Unternehmen wird am Dienstag, den 10. September um 10:00 Uhr ET (7:00 Uhr PT / 15:00 Uhr IST) an einem Fireside Chat teilnehmen. Darüber hinaus wird Theravance Biopharma während der Konferenz persönliche Meetings mit der Investment-Community abhalten.
Investoren und interessierte Parteien können über die Unternehmenswebsite, Theravance.com, im Bereich Investoren, Veranstaltungen und Präsentationen auf einen Webcast der Veranstaltung zugreifen. Die Wiederholung des Webcasts wird für 30 Tage nach der Veranstaltung auf der Unternehmenswebsite verfügbar sein, sodass Personen, die nicht live teilnehmen können, die Diskussion nachholen können.
- None.
- None.
Webcast of the event may be accessed by visiting Theravance.com, under the Investors section, Events and Presentations. Replay of the webcast will be archived on the Company's website for 30 days.
About Theravance Biopharma
Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference® in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Ampreloxetine, its late-stage investigational once-daily norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA), has the potential to be a first in class therapy effective in treating a constellation of cardinal symptoms in MSA patients. The Company is committed to creating/driving shareholder value.
For more information, please visit www.theravance.com.
THERAVANCE BIOPHARMA®, THERAVANCE® and the Cross/Star logo are registered trademarks of the Theravance Biopharma group of companies (in the U.S. and certain other countries).
YUPELRI® is a registered trademark of Mylan Specialty L.P., a Viatris company. Trademarks, trade names or service marks of other companies appearing in this press release are the property of their respective owners.
Contact:
investor.relations@theravance.com
650-808-4045
View original content to download multimedia:https://www.prnewswire.com/news-releases/theravance-biopharma-to-participate-in-an-upcoming-investor-conference-302231359.html
SOURCE Theravance Biopharma, Inc.
FAQ
When is Theravance Biopharma (TBPH) participating in the H.C. Wainwright Global Investment Conference?
Where can I watch the webcast of Theravance Biopharma's (TBPH) Fireside Chat?
How long will the replay of Theravance Biopharma's (TBPH) conference webcast be available?
What type of investor engagement is Theravance Biopharma (TBPH) offering at the conference?
